| • | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
| • | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
| • | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
| • | our inability to pay dividends on our common stock; |
| • | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes; |
| • | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
| • | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; |
| • | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and |
| • | other purposes and other disadvantages compared to our competitors who have less debt. |
In the short term, we expect to incur costs in connection in the pursuit of our Initial Business Combination plans. We cannot assure you that our plans to raise capital or to complete our Initial Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception were organizational activities, those necessary to prepare for the initial public offering, and identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our business combination. We generate non-operating income in the form of interest income on marketable securities. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a business combination.
For the year ended December 31, 2022, we had net income of $12,854,233. Our net income consisted of interest income earned in the amount of $3,376,559 on the funds in Trust and operating expenses that total $1,532,260, a gain of $11,640,000 reflecting the change in fair value of derivative warrant liability associated with the warrants issued as part of the Units sold in the Public Offering and the Private Placement Warrants and income tax expense of $630,066.
For the period from February 9, 2021 (inception) through December 31, 2021, we had net income of $11,639,507, which consists of formation and administrative costs of $640,595 which were offset by net other income of $12,280,102. Other income consisted of interest income on the funds in Trust of $16,146 and an increase in the fair value of the warrant liabilities of $17,270,000 which were offset by warrant related costs of $926,044 and excess fair value of private placement warrants over proceeds of $4,080,000.
Going Concern Considerations, Liquidity and Capital Resources
On November 2, 2021, we consummated the initial public offering of 23,000,000 units at a price of $10.00 per unit, generating gross proceeds of $230,000,000. Simultaneously with the closing of the initial public offering, we consummated the sale of 12,000,000 private placement warrants (to the sponsor and underwriters at a price of $10.00 per unit, generating gross proceeds of $6,550,000.
Following the initial public offering and the sale of the private placement units, a total of $234,600,000 was placed in the trust account and we had $2,817,141 of cash held outside of the trust account, after payment of costs related to the initial public offering, and available for working capital purposes. We incurred $13,355,589 in transaction costs, including $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $705,589 of other costs.
For the period from February 9, 2021 (inception) through December 31, 2021, cash used in operating activities was $1,128,074, consisting primarily of net income of $11,639,507, offset by interest income on the funds held in the Trust $16,146 and a decrease in the fair value of the warrant liabilities of $17,270,000 which were offset by warrant related costs of $926,044 and excess fair value of private placement warrants over proceeds of $4,080,000. Changes in operating assets and liabilities used $487,509 of cash from operating activities.
39